Tech Company Financing Transactions
Pamlico BioPharma Funding Round
Pamlico BioPharma, operating out of Oklahoma City, secured $2.2 million from Accele BioPharma and private investors.
Transaction Overview
Company Name
Announced On
5/1/2015
Transaction Type
Venture Equity
Amount
$2,200,000
Round
Series A
Investors
Accele BioPharma (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance research and development of human antibody therapeutics and diagnostics for infectious diseases and cancer.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
865 Research Pkwy. 400
Oklahoma City, OK 73104
USA
Oklahoma City, OK 73104
USA
Phone
Website
Email Address
Overview
Pamlico BioPharma, Inc. develops fully-human monoclonal antibodies (hmAb) for the rapid diagnosis and treatment of infectious diseases and cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Clayton Duncan
Chief Financial Officer
Joe Jones
President
Richard Gammans
Browse more venture capital transactions:
Prev: 5/1/2015: The Daily Dot venture capital transaction
Next: 5/1/2015: HydroBio venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs